A computational prospective on isoform-selective CB2 inhibitors

被引:0
|
作者
Zhao, Yi [1 ]
Wang, Ying [2 ]
Wang, Huibin [1 ]
Hu, Baichun [3 ,4 ]
Luo, Zhaohu [2 ]
Zhang, Fengjiao [2 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang 110016, Peoples R China
[2] Shenyang Pharmaceut Univ, Wuya Coll Innovat, Shenyang 110016, Peoples R China
[3] Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Peoples R China
[4] Shenyang Pharmaceut Univ, Sch Pharmaceut Engn, Shenyang 110016, Peoples R China
关键词
CB1R INVERSE AGONIST; CANNABINOID RECEPTOR; OVERWEIGHT PATIENTS; MOLECULAR-DYNAMICS; ACCURATE DOCKING; DISCOVERY; POTENT; GLIDE; ANTAGONIST; TARANABANT;
D O I
10.1039/d1nj02296b
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cannabinoid (CB) receptors play a vital role in many pathophysiological processes. Selective CB2 activation may lead to the immuno-modulatory effects of cannabinoids being experienced without the psychoactive effects of CB1 activation; however, despite intense efforts, selective and potent CB2 agonists still remain to be developed likely due to the challenges associated with their unexpected CB1 affinity. The aim of this study was therefore to illuminate the selective mechanisms of CB1 and CB2 receptors via analyzing their interaction modes with highly selective ligands. It was found that although CB1 and CB2 exhibit high sequence homology, especially at ligand binding regions, the binding pocket of CB1 is a narrow cross shaped slit that is enclosed by several hydrophobic residues, whereas the binding pocket of CB2 is large and round and therefore would allow for more flexible ligands. In fact, hydrophobic interactions mainly account for the receptor-ligand interactions of both CB1 and CB2, with the key residues that determine the receptor selectivity being MET103, PHE170, VAL196, and PHE268 for CB1, and PHE87, PHE183, PHE94, and TRP194 for CB2. Therefore, the strategy of enlarging the molecular size, increasing hydrogen bond interactions with the key residues of CB2, and furthering the geometric distribution of hydrophobic groups would improve the selectivity towards the CB2 receptor. Collectively, these data shed promising light on elucidating the selective mechanisms between CB1 and CB2, which would lay a solid foundation for the future design of selective inhibitors towards CB2.
引用
收藏
页码:12688 / 12699
页数:12
相关论文
共 50 条
  • [21] Targeting the cannabinoid CB2 receptor:: Mutations, modeling and development of CB2 selective ligands
    Raitio, KH
    Salo, OMH
    Nevalainen, T
    Poso, A
    Järvinen, T
    CURRENT MEDICINAL CHEMISTRY, 2005, 12 (10) : 1217 - 1237
  • [22] Morpholine containing CB2 selective agonists
    Zindell, Renee
    Riether, Doris
    Bosanac, Todd
    Berry, Angela
    Gemkow, Mark J.
    Ebneth, Andreas
    Loebbe, Sabine
    Raymond, Ernest L.
    Thome, Diane
    Shih, Daw-Tsun
    Thomson, David
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (06) : 1604 - 1609
  • [23] Novel CB2 selective bicyclic cannabinoids
    Thakur, Ganesh A.
    Shukla, Vidyanand
    Bajaj, Shama
    Makriyannis, Alexandros
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [24] The search for selective ligands for the CB2 receptor
    Huffman, JW
    CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (13) : 1323 - 1337
  • [25] Isonimesulide and Its Carborane Analogues as Isoform-Selective COX Inhibitors and Antitumor Agents
    Useini, Liridona
    Komazec, Teodora
    Laube, Markus
    Loennecke, Peter
    Schaedlich, Jonas
    Mijatovic, Sanja
    Maksimovic-Ivanic, Danijela
    Pietzsch, Jens
    Hey-Hawkins, Evamarie
    ADVANCED THERAPEUTICS, 2023, 6 (08)
  • [26] Isoform-selective regulation of mammalian cryptochromes
    Miller, Simon
    Son, You Lee
    Aikawa, Yoshiki
    Makino, Eri
    Nagai, Yoshiko
    Srivastava, Ashutosh
    Oshima, Tsuyoshi
    Sugiyama, Akiko
    Hara, Aya
    Abe, Kazuhiro
    Hirata, Kunio
    Oishi, Shinya
    Hagihara, Shinya
    Sato, Ayato
    Tama, Florence
    Itami, Kenichiro
    Kay, Steve A.
    Hatori, Megumi
    Hirota, Tsuyoshi
    NATURE CHEMICAL BIOLOGY, 2020, 16 (06) : 676 - +
  • [27] Exploration of the binding pocket of histone deacetylases: the design of potent and isoform-selective inhibitors
    Uba, Abdullahi Ibrahim
    Yelekci, Kemal
    TURKISH JOURNAL OF BIOLOGY, 2017, 41 (06) : 901 - 918
  • [28] Selective Assembly of Na,K-ATPase α2β2 Heterodimers in the Heart DISTINCT FUNCTIONAL PROPERTIES AND ISOFORM-SELECTIVE INHIBITORS
    Habeck, Michael
    Tokhtaeva, Elmira
    Nadav, Yotam
    Ben Zeev, Efrat
    Ferris, Sean P.
    Kaufman, Randal J.
    Bab-Dinitz, Elizabeta
    Kaplan, Jack H.
    Dada, Laura A.
    Farfel, Zvi
    Tal, Daniel M.
    Katz, Adriana
    Sachs, George
    Vagin, Olga
    Karlish, Steven J. D.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (44) : 23159 - 23174
  • [29] Benzoxepinones: A new isoform-selective class of tumor associated carbonic anhydrase inhibitors
    Grandane, Aiga
    Nocentini, Alessio
    Werner, Thomas
    Zalubovskis, Raivis
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (11)
  • [30] Design and synthesis of benzodiazepine analogs as isoform-selective human lysine deacetylase inhibitors
    Reddy, D. Rajasekhar
    Ballante, Flavio
    Zhou, Nancy J.
    Marshall, Garland R.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 127 : 531 - 553